Physician profile
John Christofer Dali
NPI 1023083177
$6,102.55
in general payments reported to CMS, 2019-2025
11 companies · $937 in 2025
The $937 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $30.73 · 2021: $96.26 · 2022: $95.79 · 2023: $4,745 · 2024: $50.23 · 2025: $937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $646 · Travel and Lodging: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $645.93 |
| Travel and Lodging | $586.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $4,518.57 | 2023 | Spine Truss System |
| Philips North America LLC | $782.25 | 2025 | Igt Devices Undivided, Phoenix, Igt Devices Systems Undivided |
| Angiodynamics, INC. | $174.94 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $142.27 | 2023-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Venaseal |
| Nuvasive, INC. | $135.15 | 2019 | |
| Dexcom, INC. | $97.68 | 2023 | Dexcom G6 Transmitter |
| Integra Lifesciences Corporation | $70.33 | 2021 | |
| Cardiovascular Systems INC. | $68.49 | 2019-2021 | |
| Organogenesis INC. | $67.52 | 2025 | Affinity |
| Abbott Laboratories | $24.05 | 2025 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $21.30 | 2025 | Gore Viabahn Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.